Search: id:"swepub:oai:DiVA.org:uu-63195" >
Functional versus c...
Functional versus chemical diversity: is biodiversity important for drug discovery?
- Article/chapterEnglish2002
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-63195
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-63195URI
-
https://doi.org/10.1016/S0165-6147(02)02007-2DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Prospecting the full biodiversity of nature to find leads for new drugs is not necessary. Because finding leads is aimed at identifying biological activity, structure is of secondary importance. Furthermore, although natural chemical diversity might be unrivalled, functional diversity is bound to be considerably less. It is likely that many millions of chemically distinct molecules exist in nature but it is inconceivable that the number of different biological functions is near this number. This is corroborated by knowledge obtained from the genome sequences of an increasing number of species. It is unlikely that ligands for specific molecular targets are restricted to one species and even individual compounds are often found in more than one species. Important molecular mechanisms are likely to be ubiquitous and there are no a priori reasons to assume that some are restricted to, for example, tropical rainforests. Thus, there are no obvious advantages of ‘biodiversity prospecting’, which will, possibly, endanger fragile ecosystems in the search for rare species.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Bohlin, LarsUppsala universitet,Avdelningen för farmakognosi
(author)
-
Uppsala universitetAvdelningen för farmakognosi
(creator_code:org_t)
Related titles
-
In:TIPS - Trends in Pharmacological Sciences23:5, s. 225-2310165-61471873-3735
Internet link
Find in a library
To the university's database